For more information, visit http://www.bio-rad.com/CheckoutPrecis... For a primary antibody to be selected as a PrecisionAb Antibody, it must be highly specific, highly sensitive, and pass a rigorous validation process that includes consistent performance from batch to batch. Out of throusands of primary antibodies screened, only a few are admitted into the elite PrecisionAb Antibody category. Try PrecisionAb Antibodies and see how you can generate reproducible data without wasting time and resources on optimization. PrecisionAb Validated Western Blotting Antibodies offer researchers • High specificity and sensitivity – selected for low nonspecific binding, correct target molecular weight, and the strongest signal on a western blot • Reproducible results – stringent QC requirements ensure consistent lot-to-lot performance • Trial size for every antibody (2 applications) - conveniently evaluate western blot performance • Confidence in your data – positive control lysate provided for each antibody; validation protocol included We Are Bio-Rad. Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges. Connect with Bio-Rad Antibodies Online: Website: https://www.bio-rad-antibodies.com/ LinkedIn: https://www.linkedin.com/showcase/bio... Facebook: https://www.facebook.com/BioRadAntibo... Twitter: https://twitter.com/BioRadAbs Pinterest: https://www.pinterest.com/BioRadAbs/ Instagram: @BioRadLabs Snapchat: @BioRadLabs
How Does an Antibody Become a PrecisionAb™ Antibody?
Video Nov 24, 2017
Killing Cancer Cells with the Help of Infrared LightVideo
Near-infrared photoimmunotherapy uses an antibody–photoabsorber conjugate that binds to cancer cells. When near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die.WATCH NOW
Fighting Cancer with Immuno-oncology and Quantitative PathologyVideo
Discover how scientists are harnessing the body's own immune system to fight cancer, and how they are using quantitative pathology solutions from PerkinElmer to better understanding the interactions between the immune system and cancer, and to identify biomarkers for translational research.WATCH NOW